Clinical Trial Update: Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing the efficacy and safety of abatacept in combination with a JAK inhibitor for refractory rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• abatacept (generic) (abatacept)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Abatacept, Treatment Compliance | Phase 3 | Status: UNKNOWN